<DOC>
	<DOCNO>NCT00482287</DOCNO>
	<brief_summary>The purpose study evaluate safety , pharmacokinetic pharmacodynamic effect escalate dos MTR105 wean bypass hypotensive population cardiac surgery patient .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics MTR105 Hypotensive Cardiac Surgery Patients</brief_title>
	<detailed_description>The study prospective , randomize , four-arm , dose-escalating , double blind , placebo control study evaluate safety , pharmacokinetics , pharmacodynamics four dose level MTR105 patient undergo cardiac surgery utilize cardiopulmonary bypass present hypotension upon wean bypass .</detailed_description>
	<mesh_term>Hypotension</mesh_term>
	<criteria>Men woman age 18 year old Referred cardiac surgery require use CPB . Elective urgent surgery ( non emergency operation ) . LVEF â‰¥40 base cardiac catheterization result Normal renal function study entry Normal hepatic function ( within normal laboratory range ) study entry Normal coagulation status study entry judge PT , PTT , fibrinogen platelet count . Willingness participate study adhere study design . Willingness sign inform consent form . Emergency operation Pulmonary hypertension ( PA systolic pressure &gt; 60 mmHg ) Ejection fraction le 35 % wean bypass cardiac index less 1.8 Neurological event prior CVA , TIA symptomatic carotid stenosis within 1 year presenting surgery Body weight &lt; 40 Kg Pregnancy Malignancy within 1 year presenting surgery Systemic infection evidence elevated WBC fever &gt; 38.5 C Usage vasoactive medication within 24 hour except short term use vasoconstrictor induction . Participation investigational drug device study within 30 day randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>